Pilot scale Production And pre-Market Evaluation of a Cosmetic ingredient from a marine microalga
A novel, topical drug for treatment of diabetic foot infections (DFI)
GT-002 for the treatment of schizophrenia.
Secretoneurin (SN): a breakthrough blood biomarker for heart disease and sudden Cardiac Arrest risk
A revolutionary new Industry 4.0 digital spinal brace service
A novel bio-material is to dramatically decrease the cost of treatment of severe wounds and burns.
Bioactive alginates (low guluronate) to be produced in-vivo in bacteria, and by in-vitro epimerisation of high mannuronate alginates from seaweed or bacteria. They will be used for wound healing, health supportive fish feed, fish vaccines and also combined with biopolymers for enhanced performance.
The photochemical internalisation (pci) technology will be used for site-specific enhancement of the therapeutic effect of anti-cancer drugs in a clinical trial on patients with head, neck and other types of cancer